• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
IGC Pharma Reports Q3 Revenue Decline and Higher Net Loss
21:16
IGC Pharma released FY2026 Q2 earnings on November 14 During-Market (EST), actual revenue USD 191 K (forecast USD 383 K), actual EPS USD -0.0201 (forecast USD -0.02)
21:00
IGC Pharma released FY2026 Semi-Annual Earnings on November 14 During-Market EST, actual revenue USD 519 K, actual EPS USD -0.0394
21:00
Nov10
IGC Pharma to Release FY2026 Q2 Earnings on November 17 During-Market EST, Forecast Revenue USD 383K, EPS USD -0.02
00:08
Aug15
IGC Pharma released FY2026 Q1 earnings on August 14 (EST), actual revenue USD 328K (forecast USD 326K), actual EPS USD -0.0192 (forecast USD -0.03)
03:00
Aug5
IGC Pharma Reports Promising Preclinical Results for Alzheimer's Disease Drug Candidate
13:01

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 191 K, Net Income -1.821 M, EPS -0.0201

Aug14
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 328 K, Net Income -1.599 M, EPS -0.0192

Jun27
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 330 K, Net Income -1.197 M, EPS -0.015

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More